Keywords
Documents disponibles dans cette catégorie (5)
sorted by (Issue date descending, Issue date descending, System of projection of the document ascending) | Add the result to the basket | Make a suggestion | Refine your search
Extend search on down-posting(s)
Article
Heinen A ; Schnabel A ; Brück N ; Smitka M ; Wolf C ; Lucas N ; Dollinger S ; Hahn G ; Gunther C ; Berner R ; Lee-Kirsch MA ; Schuetz C | England | 6/04/2021Article
Aeschlimann FA, Author ; Aeschlimann FA ; Fremond ML ; Duffy D ; Rice GI ; Charuel JL ; Bondet V ; Saire E ; Neven B ; Bodemer C ; Balu L ; Gitiaux C ; Crow YJ ; Bader-Meunier B | 2018Comment in: Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib. [Brain. 2018] Comment on: JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. [Brain. 2018]Article
Allenbach Y, Author ; Allenbach Y ; Toquet S ; Landon-Cardinal O ; Benveniste O | 2018Comment on: JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. [Brain. 2018] A child with severe juvenile dermatomyositis treated with ruxolitinib. [Brain. 2018]Article
Ladislau L, Author ; Suarez-Calvet X ; Toquet S ; Landon-Cardinal O ; Amelin D ; Depp M ; Rodero MP ; Hathazi D ; Duffy D ; Bondet V ; Preusse C ; Bienvenu B ; Rozenberg F ; Roos A ; Benjamim CF ; Gallardo E ; Illa I ; Mouly V ; Stenzel W ; Butler Browne G ; Benveniste O ; Allenbach Y | 2018Comment in: Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib. [Brain. 2018] A child with severe juvenile dermatomyositis treated with ruxolitinib. [Brain. 2018]